KANK2

KANK2 is an ankyrin-repeat scaffold protein that coordinates integrin adhesion dynamics, microtubule capture, and transcriptional coactivator localization. At focal adhesions, KANK2 binds the talin rod domain via its KN motif—specifically partnering with talin2 at integrin αVβ5 adhesion complexes—where it activates talin/integrins while weakening the talin-actomyosin linkage, thereby reducing integrin-ligand bond strength, promoting central adhesion sliding, and regulating cell migration speed (PMID:27548916, PMID:37460977); its ankyrin domain engages KIF21A to link these adhesions to the cortical microtubule stabilization complex, and loss of KANK2 increases sensitivity to microtubule poisons (PMID:29183992, PMID:32195252). In the cytoplasm, KANK2 sequesters steroid receptor coactivators SRC-2 and SRC-3, a function regulated by casein kinase II-mediated phosphorylation downstream of estrogen signaling and disrupted by a missense mutation (p.Ala670Val) that causes palmoplantar keratoderma and woolly hair (PMID:17476305, PMID:24671081). KANK2 also interacts with apoptosis-inducing factor (AIF) in mitochondria to suppress caspase-independent apoptosis; apoptotic stimuli trigger KANK2 degradation and AIF nuclear translocation (PMID:22371500).

1. 2007 High

   Establishing KANK2 as a cytoplasmic anchor for steroid receptor coactivators resolved how SRCs are retained outside the nucleus and revealed that estrogen signaling releases them via casein kinase II phosphorylation of KANK2's PEST domain.

   Evidence Co-IP, subcellular fractionation, kinase assays, and gain/loss-of-function experiments in cultured cells

   PMID:17476305

   Open questions at the time

   • Whether KANK2-SRC sequestration operates in all steroid hormone pathways or is estrogen-specific
   • Structural basis of SRC recognition by KANK2
   • In vivo physiological significance of this sequestration mechanism
2. 2012 High

   Demonstrating that KANK2 directly binds AIF in mitochondria and suppresses caspase-independent apoptosis revealed a second, compartmentally distinct function for the scaffold and showed that apoptotic stimuli liberate AIF by degrading KANK2.

   Evidence Co-IP, subcellular fractionation, overexpression and knockdown with apoptosis readouts

   PMID:22371500

   Open questions at the time

   • The protease or pathway responsible for KANK2 degradation upon apoptotic stimuli
   • Whether KANK2's adhesion and mitochondrial pools are independently regulated
   • Structural details of the KANK2–AIF interaction
3. 2014 High

   Identification of a causative KANK2 missense mutation in palmoplantar keratoderma/woolly hair families connected the SRC-sequestration mechanism to human disease and showed the mutation specifically disrupts cytoplasmic retention of SRC-2/SRC-3 in epidermal basal cells.

   Evidence Whole-exome sequencing, immunofluorescence of SRC coactivators, and transactivation assays in patient-derived keratinocytes

   PMID:24671081

   Open questions at the time

   • Which downstream transcriptional programs are deregulated in affected keratinocytes
   • Whether other KANK2 functions (adhesion, apoptosis) contribute to the skin phenotype
4. 2016 High

   Defining KANK2 as a talin-binding protein that localizes to the FA belt and central adhesions established its role as a mechanical regulator: it activates talin/integrins while uncoupling the talin-actomyosin linkage, reducing force transmission and controlling migration speed.

   Evidence Co-IP, pulldown, FRAP, traction force microscopy, live-cell imaging, and siRNA knockdown in migrating cells

   PMID:27548916

   Open questions at the time

   • How KANK2 simultaneously activates talin yet weakens its F-actin linkage at the structural level
   • Whether KANK2's adhesion role and SRC-sequestration role are coupled or fully independent
5. 2017 High

   Crystal structures of the KANK2 ankyrin domain bound to a KIF21A peptide revealed the atomic basis for microtubule-motor recruitment to adhesion sites, showing KIF21A is recognized by two distinct pockets and adopts helical conformations upon binding.

   Evidence X-ray crystallography with site-directed mutagenesis and biochemical binding assays

   PMID:29183992

   Open questions at the time

   • How KANK2 coordinates simultaneous binding of KIF21A and other ankyrin-domain partners
   • Whether KANK1 and KANK2 compete for KIF21A at adhesion sites in vivo
6. 2020 High

   Proteomic identification of KANK2 as a component of integrin αVβ5 adhesion complexes linked to the cortical microtubule stabilization complex clarified why KANK2 loss increases sensitivity to microtubule poisons and reduces migration.

   Evidence Mass spectrometry of isolated integrin adhesion complexes, siRNA knockdown, drug sensitivity and migration assays

   PMID:32195252

   Open questions at the time

   • Whether KANK2 functions at other integrin heterodimer complexes beyond αVβ5
   • The full composition of the KANK2-containing CMSC at αVβ5 adhesions
7. 2022 Medium

   Showing that HSP70 physically interacts with KANK2 and stabilizes its anti-apoptotic function in septic lung injury extended the AIF-sequestration model by identifying an upstream regulator that protects KANK2 from degradation.

   Evidence Co-IP, siRNA knockdown, mouse CLP sepsis model, LPS-treated human alveolar epithelial cells

   PMID:35327602

   Open questions at the time

   • Single-lab finding; independent replication needed
   • Whether HSP70 stabilizes KANK2 protein levels or modulates the KANK2–AIF interaction directly
   • Relevance to non-pulmonary tissues
8. 2023 Medium

   Demonstrating that KANK2 functionally partners with talin2 (not talin1) at αVβ5 adhesions refined the molecular specificity of KANK2's adhesion-microtubule coupling and explained isoform-specific phenotypes in microtubule dynamics and drug sensitivity.

   Evidence Selective siRNA knockdown of talin1/2 and KANK1/2, integrin adhesion complex isolation, live-cell confocal imaging of microtubule dynamics, migration assays

   PMID:37460977

   Open questions at the time

   • Single-lab finding; structural basis for talin2 selectivity over talin1 not resolved
   • Whether talin2 preference holds in all cell types and integrin contexts

• How KANK2's three major functions—focal adhesion mechanotransduction, SRC coactivator sequestration, and mitochondrial AIF regulation—are coordinated within a single cell, and whether distinct KANK2 pools are independently regulated, remains unresolved.
• No study has simultaneously measured adhesion, transcriptional, and apoptotic outputs of KANK2
• Post-translational regulation beyond CKII phosphorylation is poorly characterized
• In vivo knockout phenotypes in mammalian models have not been systematically described